Perth, Australia. Solbec Pharmaceuticals Ltd (ASX:SBP) today announced that its cancer drug, Coramsine ™, is effective in both treating, and from preliminary results, preventing, mesothelioma in a mouse model of the cancer. Treatment with Coramsine ™ in combination with the immune triggering compound, CpG, gave total remission of the mesothelioma. This was a much greater
Archive for the 'Solbec Pharmaceuticals Ltd' Category
Last update: April 01, 2019. 03:30:08 pm.